Effect of tetanus toxoid powder needleless injection on the concentration of serum antibody IgG in mice.
- Author:
Jia-Bo WANG
1
;
Xu ZHOU
;
Zhe-Wei WANG
;
Cheng JIN
;
Xiao-He XIAO
Author Information
1. China Military Institute of Chinese Materia Medica, 302 Military Hospital, Beijing 100039, China.
- Publication Type:Journal Article
- MeSH:
Adjuvants, Immunologic;
administration & dosage;
Aluminum Hydroxide;
administration & dosage;
Animals;
Drug Compounding;
Female;
Immunoglobulin G;
blood;
Injections, Jet;
Male;
Mice;
Particle Size;
Powders;
Tetanus Toxoid;
administration & dosage;
immunology
- From:
Acta Pharmaceutica Sinica
2009;44(12):1406-1409
- CountryChina
- Language:Chinese
-
Abstract:
In this study, a self-designed powder needleless injection system was compared with subcutaneous injection using a needle and syringe to deliver tetanus toxoid (TT) into mice to elicit immunity. First of all, factors influencing the prepartion of TT into powder by being absorbed on aluminium hydroxide were investigated and the micromeritic characters of Al (OH)3-TT powder were observed with optical microscope and laser particle analyzer. The results showed that salt concentration and absorption time had an enhancive effect on drug loading, but the pH value and temperature did not influence the absorption reaction obviously. The absorption reaction was optimized with sodium chloride concentration of 0.4 mol x L(-1) and lasting for 10 min. The average diameter of Al(OH)3-TT powder prepared with conditions optimized above was (60.6 +/- 4.4) microm. The immunization effect of TT was determined through enzyme-linked immunosorbent assay (ELISA) of the concentration of IgG antibody elicited by TT. With delivery of Al(OH)3-TT (of 30 microg TT) by powder needleless injection to mice, the IgG antibody concentration were (6.19 +/- 0.52) and (10.70 +/- 0.78) U x L(-1) after immunization of 4 and 8 weeks, respectively, while the values were (4.25 +/- 0.58) and (7.48 +/- 0.57) U x L(-1) by subcutaneous injection (of 20 microg TT) using a needle and syringe. The results suggested that the self-designed powder needleless injection of Al(OH)3-TT was comparable to subcutaneous injection with a good immunity.
